NJ A 4000
in committee"Gary Letizia Pre-Hospital Blood Transfusion Act"; authorizes advanced life support providers, under medical oversight, to administer blood products to patients in pre-hospital settings, and establishes certain reimbursement for such providers.
New Jersey · 222 · lower
Quick answers
Did NJ A 4000 pass?
Not yet. NJ A 4000 is in committee as of 2026-01-13 and has not come to a final vote. Latest recorded action (2026-01-13): Introduced, Referred to Assembly Health Committee
What is NJ A 4000 about?
NJ A 4000 is a bill in the 222 titled “"Gary Letizia Pre-Hospital Blood Transfusion Act"; authorizes advanced life support providers, under medical oversight, to administer blood products to patients in pre-hospital settings, and establishes certain reimbursement for such providers.”.
Who sponsors NJ A 4000?
Azzariti Jr., John V., M.D., Donlon, Margie, M.D. are the primary sponsors of NJ A 4000, joined by 3 cosponsors.
- Introduced
- 2026-01-13
- Latest action
- 2026-01-13 — Introduced, Referred to Assembly Health Committee
- Bill type
- bill
- Last updated
- —
Sponsors
- Azzariti Jr., John V., M.D.primary
- Donlon, Margie, M.D.primary
- Barlas, Alcosponsor
- Peterson, Erikcosponsor
- Kanitra, Paulcosponsor
Committees
Not provided by source.
Action timeline
2026-01-13
Introduced, Referred to Assembly Health Committee
introduction,referral-committee
Versions
- IntroducedCompare
Documents
Votes
Not provided by source.
Related bills
- Companion bill: S 4347
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:27:43.923511Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NJ&identifier=A 4000. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.